T. Sheskin et al., STRUCTURAL REQUIREMENTS FOR BINDING OF ANANDAMIDE-TYPE COMPOUNDS TO THE BRAIN CANNABINOID RECEPTOR, Journal of medicinal chemistry, 40(5), 1997, pp. 659-667
In order to establish the structural requirements for binding to the b
rain cannabinoid receptor (CB1), we have synthesized numerous fatty ac
id amides, ethanolamides, and some related simple derivatives and have
determined their K-i values. A few alpha-methyl- or alpha,alpha-dimet
hylarachidonoylalkylamides were also examined. In the 20:4, n-6 series
, the unsubstituted amide is inactive; N-monoalkylation, at least up t
o a branched pentyl group, leads to significant binding. N,N-Dialkylat
ion, with or without hydroxylation on one of the alkyl groups, leads t
o elimination of activity. Hydroxylation of the N-monoalkyl group at t
he omega carbon atom retains activity. In the 20:x, n-6 series, x has
to be either 3 or 4; the presence of only two double bonds leads to in
activation. In the n-3 series, the limited data reported suggest that
the derived ethanolamides are either inactive or less active than comp
arable compounds in the n-6 series. Alkylation or dialkylation of the
alpha carbon adjacent to the carbonyl group retains the level of bindi
ng in the case of anandamide (compounds 48, 49); however, alpha-monome
thylation or alpha,alpha-dimethylation of N-propyl derivatives (50-53)
potentiates binding and leads to the most active compounds seen in th
e present work (K-i values of 6.9 +/- 0.7 to 8.4 +/- 1.1 nM). We have
confirmed that the presence of a chiral center on the N-alkyl substitu
ent may lead to enantiomers which differ in their levels of binding (c
ompounds 54, 57 and 55, 56).